1. The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells
   Hae In Choi et al, 2022, Scientific Reports CrossRef
2. Dynamic Interactions of Transcription Factors and Enhancer Reprogramming in Cancer Progression
   Emily Zboril et al, 2021, Frontiers in Oncology CrossRef
3. Commentary on: Xbp1s-Ddit3, DNA damage and pulmonary hypertension
   Sarah-Eve Lemay et al, 2022, Clinical Science CrossRef
4. Understanding Immune Responses to Surgical Transplant Procedures in Stevens Johnsons Syndrome Patients
   Matias Soifer et al, 2021, Frontiers in Medicine CrossRef
5. Gene Transcription as a Therapeutic Target in Leukemia
   Alvina I. Khamidullina et al, 2021, International Journal of Molecular Sciences CrossRef
6. Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein Inhibitors
   Peng-Hsun Chase Chen et al, 2024, ACS Central Science CrossRef
7. Cadmium toxicity and autophagy: a review
   Yueting Shao et al, 2024, BioMetals CrossRef
8. Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1
   Secondra Holmes et al, 2024, ACS Medicinal Chemistry Letters CrossRef
9. Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies
   Sophia A Wild et al, 2022, eLife CrossRef
10. BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
    Li Ma et al, 2022, Cancer Biology & Therapy CrossRef